NL293572A
(fr)
|
1962-06-07 |
|
|
|
CH478818A
(de)
|
1965-10-22 |
1969-09-30 |
Ciba Geigy |
Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen
|
CH480410A
(de)
|
1967-01-09 |
1969-10-31 |
Geigy Ag J R |
Verfahren zur Herstellung von wasserlöslichen Azopyrimidinfarbstoffen
|
CA961052A
(en)
|
1967-01-12 |
1975-01-14 |
Max Schellenbaum |
N-2-ethylhexyl-n'-aryl ureas and preparation containing them
|
US3608087A
(en)
|
1968-06-21 |
1971-09-21 |
Merck & Co Inc |
Feed compositions
|
US3887329A
(en)
|
1969-05-05 |
1975-06-03 |
Ciba Geigy Ag |
Hexamethyl phosphotriamide-dye compositions
|
BE756953A
(fr)
|
1969-10-02 |
1971-04-01 |
Merck & Co Inc |
Potentialisation d'antibiotiques
|
US3686238A
(en)
|
1970-01-19 |
1972-08-22 |
Syntex Corp |
Glycerol esterified with 2-naphthyl-acetic acids and fatty acids
|
US3852434A
(en)
|
1970-09-11 |
1974-12-03 |
Merck & Co Inc |
Potentiation of ({31 ) cis-1,2-epoxypropyl)phosphonic acid and analogues thereof
|
US3690834A
(en)
|
1971-01-11 |
1972-09-12 |
Syva Co |
Ligand determination with spin labeled compounds by receptor displacement
|
US3966744A
(en)
|
1971-01-11 |
1976-06-29 |
Syva Company |
Spin labeled compounds
|
DE2106585A1
(de)
|
1971-02-11 |
1972-08-24 |
Farbenfabriken Bayer Ag, 5090 Leverkusen |
Aminothiodiazole und Thiodiazol-Azofarbstoffe
|
CH558137A
(de)
|
1971-05-17 |
1975-01-31 |
Ciba Geigy Ag |
Mittel zur beeinflussung des pflanzenwachstums.
|
DE2226703A1
(de)
|
1972-05-25 |
1973-12-13 |
Schering Ag |
Neue tetrahydrocarbazolderivate und verfahren zu ihrer herstellung
|
US3966764A
(en)
|
1972-07-10 |
1976-06-29 |
Syva Company |
Ligand determination of spin labeled compounds by receptor displacement-amphetamine analogs
|
US3849420A
(en)
|
1972-10-20 |
1974-11-19 |
Dow Chemical Co |
Bis-(alkylthio-and alkylsulfonyl)-pentachloroquinolines
|
CH574206A5
(fr)
|
1972-11-16 |
1976-04-15 |
Ciba Geigy Ag |
|
DE2340569C2
(de)
|
1973-08-10 |
1982-12-02 |
Bayer Ag, 5090 Leverkusen |
Azofarbstoffe
|
AT340933B
(de)
|
1973-08-20 |
1978-01-10 |
Thomae Gmbh Dr K |
Verfahren zur herstellung neuer pyrimidinderivate und ihrer saureadditionssalze
|
DE2341925A1
(de)
|
1973-08-20 |
1975-03-06 |
Thomae Gmbh Dr K |
Neue pyrimidinderivate und verfahren zu ihrer herstellung
|
US4057559A
(en)
|
1973-10-01 |
1977-11-08 |
American Home Products Corporation |
Carbazole acetic acid derivatives
|
US4101541A
(en)
|
1973-12-21 |
1978-07-18 |
Ciba-Geigy Corporation |
3-Cyano-1,2,4-thiadiazolyl-5-czo dyestuffs
|
CH584739A5
(fr)
|
1973-12-21 |
1977-02-15 |
Ciba Geigy Ag |
|
FR2258841B1
(fr)
|
1974-01-29 |
1977-11-04 |
Ugine Kuhlmann |
|
FR2306697A1
(fr)
|
1975-04-10 |
1976-11-05 |
Sogeras |
Nouvelles pyrimidines utilisables comme medicaments antidiabetiques et hypocholesterolemiants
|
US4189579A
(en)
|
1977-05-20 |
1980-02-19 |
The Dow Chemical Company |
Aminoalkylthiopurines
|
US4139705A
(en)
|
1977-05-20 |
1979-02-13 |
The Dow Chemical Company |
Pyrazolopyrimidines
|
DE2731264A1
(de)
|
1977-07-11 |
1979-02-01 |
Boehringer Mannheim Gmbh |
Neue 1-acyl-2-cyanaziridine, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen
|
JPS6038696B2
(ja)
|
1977-12-09 |
1985-09-02 |
コニカ株式会社 |
ハロゲン化銀カラ−写真感光材料
|
US4242507A
(en)
|
1978-02-23 |
1980-12-30 |
Fujisawa Pharmaceutical Co., Ltd. |
Sulfonic acid esters
|
DE2831580C2
(de)
|
1978-07-18 |
1980-09-18 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Verfahren und Reagens zur Bestimmung von Glycerin
|
DE2831850A1
(de)
|
1978-07-20 |
1980-02-07 |
Basf Ag |
N-arylsulfonylpyrrole, ihre herstellung und diese enthaltende therapeutische mittel
|
DE2906603A1
(de)
|
1979-02-21 |
1980-09-04 |
Boehringer Mannheim Gmbh |
N-substituierte aziridin-2-carbonsaeurederivate, verfahren zu deren herstellung sowie diese substanzen enthaltende arzneimittel
|
US4343804A
(en)
|
1979-03-26 |
1982-08-10 |
A. H. Robins Company, Inc. |
4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds
|
EP0053678A1
(fr)
|
1980-12-05 |
1982-06-16 |
BASF Aktiengesellschaft |
Amino-5-phényl-1-cyano-4-pyrazoles, herbicides les contenant, leur procédé de préparation et leur application comme herbicides
|
DOP1981004033A
(es)
|
1980-12-23 |
1990-12-29 |
Ciba Geigy Ag |
Procedimiento para proteger plantas de cultivo de la accion fitotoxica de herbicidas.
|
US4476248A
(en)
|
1983-02-28 |
1984-10-09 |
The Upjohn Company |
Crystallization of ibuprofen
|
DE3334455A1
(de)
|
1983-03-04 |
1984-09-06 |
Bayer Ag, 5090 Leverkusen |
Guanidin - derivate
|
US4612376A
(en)
|
1983-03-25 |
1986-09-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent
|
ZA848275B
(en)
|
1983-12-28 |
1985-08-28 |
Degussa |
New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring
|
DE3406329A1
(de)
|
1984-02-22 |
1985-08-22 |
Merck Patent Gmbh, 6100 Darmstadt |
Pyridone
|
DE3601196A1
(de)
|
1986-01-17 |
1987-07-23 |
Merck Patent Gmbh |
1,4-dihydropyridine
|
US4810699A
(en)
|
1987-02-20 |
1989-03-07 |
American Home Products Corporation |
Substituted 1,3,4,9-tetrahydropyrano[3,4,-b]indole-1-acetic acids, pharmaceutical compositions containing them, and methods for treating inflammatory conditions and for analgesic purposes using them
|
US4782076A
(en)
|
1988-03-01 |
1988-11-01 |
American Home Products Corporation |
Substituted 2,3,4,9-tetrahydro-1H-carbazole-1-acetic acid derivatives, composition and use
|
PT95692A
(pt)
|
1989-10-27 |
1991-09-13 |
American Home Prod |
Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
|
US5221678A
(en)
|
1990-07-26 |
1993-06-22 |
Merck Frosst Canada, Inc. |
(quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
|
DE4208254A1
(de)
|
1992-03-14 |
1993-09-16 |
Hoechst Ag |
Substituierte pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel und fungizid
|
TW237456B
(fr)
|
1992-04-09 |
1995-01-01 |
Ciba Geigy |
|
FR2692575B1
(fr)
|
1992-06-23 |
1995-06-30 |
Sanofi Elf |
Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
DE4241632A1
(de)
|
1992-12-10 |
1994-06-16 |
Thomae Gmbh Dr K |
Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
US5998499A
(en)
|
1994-03-25 |
1999-12-07 |
Dentsply G.M.B.H. |
Liquid crystalline (meth)acrylate compounds, composition and method
|
BR9407799A
(pt)
|
1993-10-12 |
1997-05-06 |
Du Pont Merck Pharma |
Composição de matéria método de tratamento e composição farmaceutica
|
TW530047B
(en)
|
1994-06-08 |
2003-05-01 |
Pfizer |
Corticotropin releasing factor antagonists
|
BR9508900A
(pt)
|
1994-09-09 |
1997-12-30 |
Nippon Shinyaku Co Ltd |
Derivado heterocíclico e medicamento
|
US5691364A
(en)
|
1995-03-10 |
1997-11-25 |
Berlex Laboratories, Inc. |
Benzamidine derivatives and their use as anti-coagulants
|
US6956047B1
(en)
|
1995-06-06 |
2005-10-18 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
US6403599B1
(en)
|
1995-11-08 |
2002-06-11 |
Pfizer Inc |
Corticotropin releasing factor antagonists
|
KR0169813B1
(ko)
|
1995-07-12 |
1999-01-15 |
김종인 |
4-아미노-3-아실나프티리딘 유도체
|
US5849759A
(en)
|
1995-12-08 |
1998-12-15 |
Berlex Laboratories, Inc. |
Naphthyl-substituted benzimidazole derivatives as anti-coagulants
|
US5948786A
(en)
|
1996-04-12 |
1999-09-07 |
Sumitomo Pharmaceuticals Company, Limited |
Piperidinylpyrimidine derivatives
|
US6060478A
(en)
|
1996-07-24 |
2000-05-09 |
Dupont Pharmaceuticals |
Azolo triazines and pyrimidines
|
US5776967A
(en)
|
1996-07-26 |
1998-07-07 |
American Home Products Corporation |
Pyranoindole inhibitors of COX--2
|
AR008789A1
(es)
|
1996-07-31 |
2000-02-23 |
Bayer Corp |
Piridinas y bifenilos substituidos
|
US5830911A
(en)
|
1996-08-14 |
1998-11-03 |
American Home Products Corporation |
Pyranoindole and tetrahydrocarbazole inhibitors of COX-2
|
US6008234A
(en)
|
1996-09-12 |
1999-12-28 |
Berlex Laboratories, Inc. |
Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants
|
NL1010018C2
(nl)
|
1997-09-09 |
1999-03-10 |
Duphar Int Res |
Chinoline en chinazoline derivaten met corticotropine releasing factor (CRF) antagonistische werking.
|
GB9722361D0
(en)
*
|
1997-10-24 |
1997-12-17 |
Pharma Nord Uk Ltd |
Pharmaceutical formulation for treating liver disorders
|
US6861448B2
(en)
|
1998-01-14 |
2005-03-01 |
Virtual Drug Development, Inc. |
NAD synthetase inhibitors and uses thereof
|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
CA2339188A1
(fr)
|
1998-08-21 |
2000-03-02 |
Dupont Pharmaceuticals Company |
Isoxazolo¬4,5-d|pyrimidines comme antagonistes du crf
|
US6239126B1
(en)
|
1998-12-17 |
2001-05-29 |
American Home Products Corporation |
Arylpiperidine and aryl-1,2,5,6-tetra-hydropyridine urea derivatives
|
BR9916363A
(pt)
|
1998-12-18 |
2001-12-11 |
Axys Pharm Inc |
Composto, composição farmacêutica e método paratratar ou prevenir um distúrbio tromboembólico
|
CZ27399A3
(cs)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
ES2219319T3
(es)
|
1999-03-17 |
2004-12-01 |
Astrazeneca Ab |
Derivados de amida.
|
ES2287016T3
(es)
|
1999-04-28 |
2007-12-16 |
Sanofi-Aventis Deutschland Gmbh |
Derivados de diaril-acido como ligandos del receptor ppar.
|
NZ517758A
(en)
|
1999-09-17 |
2004-06-25 |
Abbott Gmbh & Co |
Pyrazolopyrimidines useful as therapeutic agents
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
US6414002B1
(en)
|
1999-09-22 |
2002-07-02 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
IL148801A0
(en)
|
1999-09-24 |
2002-09-12 |
Janssen Pharmaceutica Nv |
Antiviral compositions
|
PL354982A1
(en)
|
1999-09-30 |
2004-03-22 |
Neurogen Corporation |
Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
|
PL354784A1
(en)
|
1999-09-30 |
2004-02-23 |
Neurogen Corporation |
Certain alkylene diamine-substituted heterocycles
|
EA200200422A1
(ru)
|
1999-09-30 |
2002-10-31 |
Ньюроджен Корпорейшн |
НЕКОТОРЫЕ АЛКИЛЕНДИАМИНОЗАМЕЩЕННЫЕ ПИРАЗОЛО[1,5-а]-1,5-ПИРИМИДИНЫ И ПИРАЗОЛО[1,5-а]-1,3,5-ТРИАЗИНЫ
|
DE19947154A1
(de)
|
1999-10-01 |
2001-10-04 |
Bayer Ag |
Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
|
US6887870B1
(en)
|
1999-10-12 |
2005-05-03 |
Bristol-Myers Squibb Company |
Heterocyclic sodium/proton exchange inhibitors and method
|
GR990100388A
(el)
|
1999-11-09 |
2001-07-31 |
|
Φαρμακευτικος συνδυασμος αποτελουμενος απο χωριστες δοσολογικες μορφες σε συσκευασια συμμορφωσης (compliance package) ενος αναστολεα της αναγωγασης του υδροξυ-μεθυλο-γλουταρυλο συνενζυμου α (στατινης, statin) και ενος παραγωγου του φιμπρικου οξεος....
|
JP2003518128A
(ja)
|
1999-12-22 |
2003-06-03 |
メルク フロスト カナダ アンド カンパニー |
タンパク質チロシンホスファターゼ1b(ptp−1b)のインヒビターとなる芳香族ホスホネート
|
DE19962936A1
(de)
|
1999-12-24 |
2001-06-28 |
Bayer Ag |
Neue beta-Aminosäureverbindungen als Integrinantagonisten
|
DE60009154D1
(de)
|
1999-12-30 |
2004-04-22 |
Lundbeck & Co As H |
Phenylpiperazinyl-derivate
|
PL357589A1
(en)
|
2000-01-18 |
2004-07-26 |
Pfizer Products Inc. |
Corticotropin releasing factor antagonists
|
HUP0204474A3
(en)
|
2000-02-09 |
2004-07-28 |
Hokuriku Pharmaceutical |
1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
|
AU2001236948A1
(en)
|
2000-02-15 |
2001-08-27 |
Foster-Miller Inc. |
No voc radiation curable resin compositions
|
US6569879B2
(en)
|
2000-02-18 |
2003-05-27 |
Merck & Co., Inc. |
Aryloxyacetic acids for diabetes and lipid disorders
|
JP2003523336A
(ja)
|
2000-02-18 |
2003-08-05 |
メルク エンド カムパニー インコーポレーテッド |
糖尿病及び脂質障害のためのアリールオキシ酢酸
|
EP1261327B1
(fr)
|
2000-02-25 |
2005-04-27 |
F.Hoffmann-La Roche Ag |
Modulateurs de recepteurs de l'adenosine
|
PL365696A1
(en)
|
2000-04-12 |
2005-01-10 |
Novartis Ag |
Combination of organic compounds
|
US7034019B2
(en)
|
2000-05-08 |
2006-04-25 |
Janssen Pharmaceutica N.V. |
Prodrugs of HIV replication inhibiting pyrimidines
|
DE10024319A1
(de)
|
2000-05-17 |
2001-11-22 |
Merck Patent Gmbh |
Bisacylguanidine
|
AU2001263288A1
(en)
|
2000-05-18 |
2001-11-26 |
Neurocrine Biosciences, Inc. |
Crf receptor antagonists
|
CZ20024199A3
(cs)
|
2000-05-25 |
2004-01-14 |
F. Hoffmann-La Roche Ag |
Substituované 1-aminoalkyllaktamy a jejich použití jako antagonisty muskarinového receptoru
|
US6620821B2
(en)
|
2000-06-15 |
2003-09-16 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
US6699997B2
(en)
|
2000-06-28 |
2004-03-02 |
Teva Pharmaceutical Industries Ltd. |
Carvedilol
|
WO2002002539A1
(fr)
|
2000-06-29 |
2002-01-10 |
Abbott Laboratories |
Derives d'aryle phenylheterocyclyle sulfures et leur utilisation en tant qu'agents immunosuppresseurs anti-inflammatoires inhibant l'adherence cellulaire
|
AR028782A1
(es)
|
2000-07-05 |
2003-05-21 |
Taisho Pharmaceutical Co Ltd |
Derivados heterociclicos tetrahidropiridino o piperidino
|
US6444685B1
(en)
|
2000-07-17 |
2002-09-03 |
Wyeth |
N-(4-sulfonylaryl)Cyclylamine 2-hydroxyethylamines as beta-3 adrenergic receptor agonists
|
KR20030026979A
(ko)
|
2000-07-18 |
2003-04-03 |
야마노우치세이야쿠 가부시키가이샤 |
디시아노피리딘 유도체를 포함하는 의약
|
US6410583B1
(en)
|
2000-07-25 |
2002-06-25 |
Merck Frosst Canada & Co. |
Cyclopentanoindoles, compositions containing such compounds and methods of treatment
|
DE60128475T2
(de)
|
2000-07-25 |
2008-02-07 |
Merck & Co., Inc. |
N-substituierte indole mit anwendung in der behandlung von diabetes
|
WO2002019975A1
(fr)
|
2000-09-05 |
2002-03-14 |
Taisho Pharmaceutical Co., Ltd. |
Stimulants de la croissance des cheveux
|
ATE367802T1
(de)
|
2000-09-20 |
2007-08-15 |
Jagotec Ag |
Verfahren zur sprühtrocknung von zusammensetzungen enthaltend fenofibrat
|
US20030224058A1
(en)
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US7276249B2
(en)
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
PE20020507A1
(es)
|
2000-10-17 |
2002-06-25 |
Schering Corp |
Compuestos no-imidazoles como antagonistas del receptor histamina h3
|
WO2002032408A2
(fr)
|
2000-10-20 |
2002-04-25 |
Novartis Ag |
Compositions
|
JP4524072B2
(ja)
|
2000-10-23 |
2010-08-11 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー |
新規化合物
|
EP1347755A2
(fr)
|
2000-10-31 |
2003-10-01 |
Merck & Co., Inc. |
Derives d'acide benzopyranocarboxylique pour traiter le diabete et d'autres troubles lipidiques
|
AU2002239589B2
(en)
|
2000-11-03 |
2005-04-21 |
Neurocrine Biosciences, Inc. |
CRF receptor antagonists and methods relating thereto
|
US20020058026A1
(en)
|
2000-11-13 |
2002-05-16 |
Milton Hammerly |
HMG CoA reductase inhibitor medications combined wih CoEnzyme Q-10
|
WO2002039987A2
(fr)
|
2000-11-14 |
2002-05-23 |
Neurosearch A/S |
Mise en oeuvre de bloquants des canaux anioniques des parasites de la malaria pour traiter cette maladie
|
UA77165C2
(en)
|
2000-11-17 |
2006-11-15 |
Lilly Co Eli |
(n)-((s)-2-hydroxy-3-methyl-butyryl)-1-(l-alaninyl)-(s)-1-amino-3-methyl-4,5,6,7-tetrahydro-2h-3-benzazepin-2-one dihydrate, processes for manufacturing and pharmaceutical composition
|
WO2002040458A1
(fr)
|
2000-11-17 |
2002-05-23 |
Takeda Chemical Industries, Ltd. |
Derives d'isoxazole
|
CA2448729A1
(fr)
|
2000-11-20 |
2002-05-23 |
Biovitrum Ab |
Composes heterocycliques substitues par des groupes piperazinyle et piperidyle
|
JP3438186B2
(ja)
|
2000-12-01 |
2003-08-18 |
山之内製薬株式会社 |
糖尿病治療剤スクリーニング方法
|
US20020137755A1
(en)
|
2000-12-04 |
2002-09-26 |
Bilodeau Mark T. |
Tyrosine kinase inhibitors
|
US6545017B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Urea substituted imidazopyridines
|
US20020107262A1
(en)
|
2000-12-08 |
2002-08-08 |
3M Innovative Properties Company |
Substituted imidazopyridines
|
US6525064B1
(en)
|
2000-12-08 |
2003-02-25 |
3M Innovative Properties Company |
Sulfonamido substituted imidazopyridines
|
US6545016B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Amide substituted imidazopyridines
|
CA2433018A1
(fr)
|
2000-12-21 |
2002-06-27 |
Joel C. Barrish |
Inhibiteurs thiazolyl des tyrosine kinases de la famille tec
|
PL205343B1
(pl)
|
2001-01-26 |
2010-04-30 |
Schering Corp |
Zastosowanie inhibitora wchłaniania sterolu
|
WO2002060388A2
(fr)
|
2001-01-30 |
2002-08-08 |
Merck & Co., Inc. |
Acyl-sulfamides pour le traitement de l'obesite, du diabete et des troubles lipidiques
|
DE60234092D1
(de)
|
2001-01-30 |
2009-12-03 |
Univ Virginia |
Agonisten und antagonisten von sphingosin-1-phosphatrezeptoren
|
WO2002098878A1
(fr)
|
2001-02-08 |
2002-12-12 |
Memory Pharmaceuticals Corporation |
Trifluoromethylpurines en tant qu'inhibiteurs de la phosphodiesterase 4
|
JP2004521124A
(ja)
|
2001-02-09 |
2004-07-15 |
メルク エンド カムパニー インコーポレーテッド |
糖尿病および脂質障害用の2−アリールオキシ−2−アリールアルカン酸類
|
DE10110754A1
(de)
|
2001-03-07 |
2002-09-19 |
Bayer Ag |
Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
|
WO2002072101A1
(fr)
|
2001-03-13 |
2002-09-19 |
Bristol-Myers Squibb Pharma Company |
Ligand du recepteur de la corticoliberine, son enantiomere et ses sels pharmaceutiquement acceptables
|
WO2002079131A1
(fr)
|
2001-03-29 |
2002-10-10 |
Kansai Research Institute, Inc. |
Compose optiquement actif et composition de resine photosensible
|
WO2002081454A1
(fr)
|
2001-04-09 |
2002-10-17 |
Dr. Reddy's Laboratories Ltd. |
Derives d'acides aryliques et leur utilisation en medecine, procede de preparation de ces derives et compositions pharmaceutiques contenant lesdits derives
|
BR0209056A
(pt)
|
2001-04-20 |
2004-08-10 |
Wyeth Corp |
Derivados de heterociclilóxi-, -tióxi- e -aminobenzazol como ligantes de 5-hidroxitriptamina-6
|
JP4378597B2
(ja)
|
2001-05-10 |
2009-12-09 |
小野薬品工業株式会社 |
カルボン酸誘導体化合物およびそれらを有効成分とする薬剤
|
CN1245391C
(zh)
|
2001-06-01 |
2006-03-15 |
弗·哈夫曼-拉罗切有限公司 |
用作谷氨酸受体的嘧啶、三嗪和吡嗪衍生物
|
WO2002102313A2
(fr)
|
2001-06-19 |
2002-12-27 |
Bristol-Myers Squibb Company |
Inhibiteurs pyrimidine de la phosphodiesterase (pde) 7
|
US6825198B2
(en)
|
2001-06-21 |
2004-11-30 |
Pfizer Inc |
5-HT receptor ligands and uses thereof
|
WO2003002544A1
(fr)
|
2001-06-26 |
2003-01-09 |
Bristol-Myers Squibb Company |
Inhibiteurs n-heterocycliques d'expression tnf-alpha
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
GB0117899D0
(en)
|
2001-07-23 |
2001-09-12 |
Astrazeneca Ab |
Chemical compounds
|
WO2003026661A1
(fr)
|
2001-09-14 |
2003-04-03 |
Yamanouchi Pharmaceutical Co., Ltd. |
Accelerateur de secretion de l'insuline et nouveau derive de pyrimidine
|
CN1329372C
(zh)
|
2001-09-27 |
2007-08-01 |
杏林制药株式会社 |
二芳基硫醚衍生物及其加成盐和免疫抑制剂
|
CA2462441A1
(fr)
|
2001-10-18 |
2003-04-24 |
Pier F. Cirillo |
Composes d'uree benzo fusionnes 1,4-disubstitues utilises comme inhibiteurs des cytokines
|
SE0104334D0
(sv)
|
2001-12-19 |
2001-12-19 |
Astrazeneca Ab |
Therapeutic agents
|
GB0229931D0
(en)
|
2002-12-21 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
WO2003059378A2
(fr)
|
2001-12-29 |
2003-07-24 |
Novo Nordisk A/S |
Utilisation combinee d'un compose glp-1 et d'un autre medicament pour traiter la dyslipidemie
|
US20050043315A1
(en)
|
2002-01-02 |
2005-02-24 |
Hideo Tsutsumi |
Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them
|
US20070225351A1
(en)
|
2002-01-11 |
2007-09-27 |
Lippa Arnold S |
Methods and compositions for controlling body weight and appetite
|
AU2003205630A1
(en)
|
2002-01-18 |
2003-07-30 |
The Genetics Company Inc. |
Beta-secretase inhibitors
|
AU2003216054B2
(en)
|
2002-01-18 |
2007-01-04 |
Merck & Co., Inc. |
Selective S1P1/Edg1 receptor agonists
|
JP4430941B2
(ja)
|
2002-01-18 |
2010-03-10 |
メルク エンド カムパニー インコーポレーテッド |
Edg受容体作動薬
|
GB0201850D0
(en)
|
2002-01-26 |
2002-03-13 |
Astrazeneca Ab |
Therapeutic treatment
|
WO2003074008A2
(fr)
|
2002-03-01 |
2003-09-12 |
Merck & Co., Inc. |
Aminoalkylphosphonates et composes associes utilises en tant qu'agonistes du recepteur edg
|
CA2477423A1
(fr)
|
2002-03-01 |
2003-09-12 |
Merck & Co., Inc. |
Aminoalkylphosphonates et composes associes utilises en tant qu'agonistes du recepteur edg
|
US20080070864A1
(en)
|
2002-03-07 |
2008-03-20 |
X-Ceptor Therapeutics, Inc. |
Quinazolinone Modulators Of Nuclear Receptors
|
AU2003214110A1
(en)
|
2002-03-15 |
2003-09-29 |
Ciba Specialty Chemicals Holding Inc. |
4-aminopyrimidines and their use for the antimicrobial treatment of surfaces
|
AR039090A1
(es)
|
2002-03-22 |
2005-02-09 |
Novartis Ag |
Combinacion de compuestos organicos
|
WO2003088962A1
(fr)
|
2002-04-16 |
2003-10-30 |
Merck & Co., Inc. |
Therapie combinatoire faisant appel a un agoniste de ppar alpha/gamma
|
EP1499598A1
(fr)
|
2002-04-18 |
2005-01-26 |
Ucb, S.A. |
Composes chimiques a double activite, procedes de leur preparation et compositions pharmaceutiques
|
DE10219435A1
(de)
|
2002-05-02 |
2003-11-13 |
Bayer Cropscience Ag |
Substituierte Pyrazolo-pyrimidin-4-one
|
US6747048B2
(en)
|
2002-05-08 |
2004-06-08 |
Bristol-Myers Squibb Company |
Pyridine-based thyroid receptor ligands
|
US7057046B2
(en)
|
2002-05-20 |
2006-06-06 |
Bristol-Myers Squibb Company |
Lactam glycogen phosphorylase inhibitors and method of use
|
JP4831965B2
(ja)
|
2002-06-10 |
2011-12-07 |
エラン ファーマ インターナショナル,リミティド |
HMG−CoA還元酵素インヒビター誘導体(「スタチン」)を含むナノ粒子製剤、その新規組合せ、ならびにこれらの医薬組成物の製造
|
EP1511468A1
(fr)
|
2002-06-10 |
2005-03-09 |
Elan Pharma International Limited |
Preparation de sterols nanoparticulaires et nouvelles combinaisons de sterols
|
AR040241A1
(es)
|
2002-06-10 |
2005-03-23 |
Merck & Co Inc |
Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
|
CA2488498A1
(fr)
|
2002-06-10 |
2003-12-18 |
Elan Pharma International Limited |
Formulation de polycosanol nanoparticulaires et nouvelles combinaisons de polycosanol
|
DE60335639D1
(de)
|
2002-06-14 |
2011-02-17 |
Amylin Pharmaceuticals Inc |
Prävention und/oder behandlung von colitis ulcerosa mit pyy oder pyyä3-36ü
|
EP1549640A4
(fr)
|
2002-06-17 |
2008-08-06 |
Merck & Co Inc |
1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates et 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates utilises en tant qu'agonistes du recepteur edg
|
DE10226943A1
(de)
|
2002-06-17 |
2004-01-08 |
Bayer Ag |
Phenylaminopyrimidine und ihre Verwendung
|
GB0214254D0
(en)
|
2002-06-20 |
2002-07-31 |
Glaxo Group Ltd |
Chemical compounds
|
SE0201980D0
(sv)
|
2002-06-24 |
2002-06-24 |
Astrazeneca Ab |
Novel compounds
|
SE0201976D0
(sv)
|
2002-06-24 |
2002-06-24 |
Astrazeneca Ab |
Novel compounds
|
DE60327211D1
(de)
|
2002-06-28 |
2009-05-28 |
Glykos Finland Oy |
Therapeutische zusammensetzungen zur verwendung bei der prophylaxe oder behandlung von durchfall
|
US20040053842A1
(en)
|
2002-07-02 |
2004-03-18 |
Pfizer Inc. |
Methods of treatment with CETP inhibitors and antihypertensive agents
|
US7071210B2
(en)
|
2002-07-02 |
2006-07-04 |
Pfizer Inc. |
CETP inhibitors in combination with antihypertensive agents and uses thereof
|
AU2003252478A1
(en)
|
2002-07-10 |
2004-02-02 |
Ono Pharmaceutical Co., Ltd. |
Ccr4 antagonist and medicinal use thereof
|
JP2006514918A
(ja)
|
2002-07-23 |
2006-05-18 |
スミスクライン ビーチャム コーポレーション |
キナーゼインヒビターとしてのピラゾロピリミジン
|
WO2004009602A1
(fr)
|
2002-07-23 |
2004-01-29 |
Smithkline Beecham Corporation |
Inhibiteurs de kinase sous forme de pyrazolopyrimidines
|
EP1523314A2
(fr)
|
2002-07-23 |
2005-04-20 |
SmithKline Beecham Corporation |
Pyrazolopyrimidines en tant qu'inhibiteurs de kinases
|
WO2004013633A2
(fr)
|
2002-07-29 |
2004-02-12 |
Axxima Pharmaceuticals Ag |
Milieu et methode d'enrichissement, de purification ou d'appauvrissement de proteines de liaison a l'atp a partir d'un reservoir de proteines
|
DE60332738D1
(de)
|
2002-07-30 |
2010-07-08 |
Merck Sharp & Dohme |
Ppar alpha selektive verbindungen zur behandlung von dyslipidämie und anderen lipidstörungen
|
JP4475406B2
(ja)
|
2002-07-30 |
2010-06-09 |
メルク・シャープ・エンド・ドーム・コーポレイション |
異常脂血症および他の脂質障害の治療用のPPARα選択的化合物
|
US7241790B2
(en)
|
2002-07-30 |
2007-07-10 |
University Of Virginia Patent Foundation |
Compounds active in spinigosine 1-phosphate signaling
|
NZ537952A
(en)
|
2002-08-08 |
2008-04-30 |
Amgen Inc |
Vanilloid receptor ligands and their use in treatments
|
DE10237722A1
(de)
|
2002-08-17 |
2004-08-19 |
Aventis Pharma Deutschland Gmbh |
Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
|
AU2003256419A1
(en)
|
2002-08-21 |
2004-03-11 |
Merck & Co., Inc. |
Combination therapy using a dual ppar alpha/gamma agonist and an angiotensin ii type i receptor antagonist
|
CA2495943C
(fr)
|
2002-08-29 |
2009-07-21 |
Merck & Co., Inc. |
Indoles a activite antidiabetique
|
AU2003260085B2
(en)
|
2002-08-29 |
2008-09-11 |
Merck & Co., Inc. |
Indoles having anti-diabetic activity
|
CA2489405A1
(fr)
|
2002-09-11 |
2004-03-25 |
Yamanouchi Pharmaceutical Co., Ltd. |
Procede de criblage d'un agent pour accroitre la teneur en insuline
|
JP2006510597A
(ja)
|
2002-09-27 |
2006-03-30 |
メルク エンド カムパニー インコーポレーテッド |
置換ピリミジン類
|
US7067658B2
(en)
|
2002-09-30 |
2006-06-27 |
Bristol-Myers Squibb Company |
Pyridino and pyrimidino pyrazinones
|
WO2004033431A2
(fr)
|
2002-10-04 |
2004-04-22 |
Arena Pharmaceuticals, Inc. |
Hydroxypyrazoles et methodes prophylactiques ou de traitement de troubles lies au metabolisme
|
WO2004033710A2
(fr)
|
2002-10-09 |
2004-04-22 |
Genaissance Pharmaceuticals, Inc. |
Haplotypes du gene itgb3 et effets de doses d'atorvastatine sur le cholesterol hdl
|
US7582630B2
(en)
|
2002-10-15 |
2009-09-01 |
Smithkline Beecham Corporation |
Pyradazine compounds as GSK-3 inhibitors
|
US7129239B2
(en)
|
2002-10-28 |
2006-10-31 |
Pfizer Inc. |
Purine compounds and uses thereof
|
JP2006507302A
(ja)
|
2002-10-30 |
2006-03-02 |
メルク エンド カムパニー インコーポレーテッド |
キナーゼ阻害剤
|
WO2004041266A1
(fr)
|
2002-11-08 |
2004-05-21 |
Takeda Pharmaceutical Company Limited |
Agent de controle de la fonction recepteur
|
US7098235B2
(en)
|
2002-11-14 |
2006-08-29 |
Bristol-Myers Squibb Co. |
Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds
|
US20040110241A1
(en)
|
2002-12-06 |
2004-06-10 |
Segal Mark S. |
Materials and methods for monitoring vascular endothelial function
|
JO2397B1
(en)
|
2002-12-20 |
2007-06-17 |
ميرك شارب اند دوم كوربوريشن |
Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors
|
AU2003299791A1
(en)
|
2002-12-20 |
2004-07-22 |
Bayer Pharmaceuticals Corporation |
Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
|
AU2003299790A1
(en)
|
2002-12-20 |
2004-07-22 |
Bayer Pharmaceuticals Corporation |
Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
|
AU2003297232B2
(en)
|
2002-12-20 |
2010-02-04 |
Merck Sharp & Dohme Corp. |
1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles
|
GB0230020D0
(en)
|
2002-12-23 |
2003-01-29 |
Syngenta Ltd |
Fungicides
|
GB0230021D0
(en)
|
2002-12-23 |
2003-01-29 |
Syngenta Ltd |
Fungicides
|
PL377847A1
(pl)
|
2003-01-14 |
2006-02-20 |
Arena Pharmaceuticals Inc. |
1,2,3-Tripodstawione pochodne arylowe i heteroarylowe jako modulatory metabolizmu oraz profilaktyka i leczenie związanych z nim zaburzeń takich jak cukrzyca i hiperglikemia
|
US20070066640A1
(en)
|
2003-01-16 |
2007-03-22 |
Emiliano Castiglioni |
Heteroaryl-substituted pyrrolo'2,3-b1 pyridine derivatives as crf receptor antagonists
|
CA2512879A1
(fr)
|
2003-01-17 |
2004-08-12 |
Soumya P. Sahoo |
Derives de n-cyclohexylaminocarbonyl benzenesulfonamide
|
GB0301259D0
(en)
|
2003-01-20 |
2003-02-19 |
Novartis Ag |
Organic compounds
|
EP1594508B1
(fr)
|
2003-02-11 |
2012-08-08 |
Irm Llc |
Nouveaux composes bicycliques et compositions associees
|
TW200418829A
(en)
|
2003-02-14 |
2004-10-01 |
Avanir Pharmaceutics |
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
|
CA2515574C
(fr)
|
2003-02-18 |
2012-03-13 |
Kyorin Pharmaceutical Co., Ltd. |
Derives d'acide aminophosphonique, leurs sels d'addition et des modulateurs de recepteurs s1p
|
EP1606282B1
(fr)
|
2003-02-24 |
2008-11-12 |
Arena Pharmaceuticals, Inc. |
Derives d'aryle et heteroaryle susbtitues tenant lieu de modulateurs du metabolisme du glucose et prophylaxie et traitement de troubles associes
|
WO2004085401A1
(fr)
|
2003-03-28 |
2004-10-07 |
Pfizer Products Inc. |
Derives de 1,2,3,4-tetrahydro- et 1,2 dihydro-quinoleine et 1,2,3,4-tetrahydro-quinoxaline 1,2,4-substitues, utiles comme inhibiteurs de cetp pour le traitement de l'atherosclerose et de l'obesite
|
CN1777575B
(zh)
|
2003-04-30 |
2010-05-12 |
诺瓦提斯公司 |
作为1-磷酸-鞘氨醇受体调节剂的氨基-丙醇衍生物
|
AU2004236249A1
(en)
|
2003-04-30 |
2004-11-18 |
The Institutes Of Pharmaceutical Discovery, Llc |
Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1B
|
CA2523677A1
(fr)
|
2003-04-30 |
2004-11-11 |
Novartis Ag |
Derives d'amino-propanol comme modulateurs de recepteur de sphingosine-1-phosphate
|
TWI494102B
(zh)
|
2003-05-02 |
2015-08-01 |
Japan Tobacco Inc |
包含s-〔2(〔〔1-(2-乙基丁基)環己基〕羰基〕胺基)苯基〕2-甲基丙烷硫酯及hmg輔酶a還原酶抑制劑之組合
|
SE0301368D0
(sv)
|
2003-05-09 |
2003-05-09 |
Astrazeneca Ab |
Chemical compounds
|
US7083933B1
(en)
|
2003-05-09 |
2006-08-01 |
Prosidion Limited |
Methods for identification of modulators of OSGPR116 activity
|
CA2524867A1
(fr)
|
2003-05-15 |
2004-12-02 |
Merck & Co., Inc. |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles servant d'agonistes du recepteur s1p
|
WO2004104205A2
(fr)
|
2003-05-16 |
2004-12-02 |
Merck & Co., Inc. |
Preparation enzymatique d'esters d'indole chiraux
|
CA2524054C
(fr)
|
2003-05-19 |
2012-04-24 |
Irm Llc |
Composes immunosuppresseurs et compositions
|
AU2004251146A1
(en)
|
2003-05-19 |
2005-01-06 |
Irm, Llc |
Immunosuppressant compounds and compositions
|
EP1644367B1
(fr)
|
2003-05-19 |
2015-10-14 |
Novartis AG |
Compositions et composes immunosuppresseurs
|
MY150088A
(en)
|
2003-05-19 |
2013-11-29 |
Irm Llc |
Immunosuppressant compounds and compositions
|
US6987118B2
(en)
|
2003-05-21 |
2006-01-17 |
Pfizer Inc. |
Tetrahydroisoquinoline derivatives as PPAR-alpha activators
|
EP1635773A2
(fr)
|
2003-06-06 |
2006-03-22 |
Merck & Co., Inc. (a New Jersey corp.) |
Polytherapie pour le traitement de l'hypertension
|
AU2003902882A0
(en)
|
2003-06-10 |
2003-06-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Piperidyl derivatives
|
GB0313612D0
(en)
|
2003-06-12 |
2003-07-16 |
Novartis Ag |
Organic compounds
|
AR045047A1
(es)
|
2003-07-11 |
2005-10-12 |
Arena Pharm Inc |
Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
|
EA010023B1
(ru)
|
2003-07-14 |
2008-06-30 |
Арена Фармасьютикалз, Инк. |
Конденсированные арильные и гетероарильные производные в качестве модуляторов метаболизма и для профилактики и лечения расстройств, связанных с нарушением метаболизма
|
WO2005012221A1
(fr)
|
2003-08-04 |
2005-02-10 |
Ono Pharmaceutical Co., Ltd. |
Compose d'ether de diphenyle, sa methode de preparation et d'utilisation
|
JP4607879B2
(ja)
|
2003-08-15 |
2011-01-05 |
ノバルティス アーゲー |
新生物疾患、炎症および免疫障害の処置に有用な2,4−ピリミジンジアミン
|
CA2535704C
(fr)
|
2003-08-28 |
2012-12-11 |
Novartis Ag |
Derives d'aminopropanol
|
ES2754221T3
(es)
|
2003-08-29 |
2020-04-16 |
Ono Pharmaceutical Co |
Compuesto capaz de unirse al receptor de S1P y uso farmacéutico del mismo
|
CN101407471A
(zh)
|
2003-08-29 |
2009-04-15 |
小野药品工业株式会社 |
能够结合s1p受体的化合物及其药物用途
|
EP1662876A4
(fr)
|
2003-09-02 |
2009-01-14 |
Merck & Co Inc |
Nouvelles formes cristallines d'un sel d'acide phosphorique d'un inhibiteur de dipeptidyl peptidase-iv
|
WO2005023762A1
(fr)
|
2003-09-04 |
2005-03-17 |
Abbott Laboratories |
Derives de pyrrolidine-2-carbonitrile et leur utilisation comme inhibiteurs de la dipeptidyle peptidase-iv (dpp-iv)
|
US7732442B2
(en)
|
2003-09-05 |
2010-06-08 |
Ono Pharmaceutical Co., Ltd. |
Chemokine receptor antagonist and medical use thereof
|
MY148123A
(en)
|
2003-09-05 |
2013-02-28 |
Vertex Pharma |
Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
|
JP2007513058A
(ja)
|
2003-09-08 |
2007-05-24 |
武田薬品工業株式会社 |
ジペプチジルぺプチダーゼ阻害剤
|
US7790734B2
(en)
|
2003-09-08 |
2010-09-07 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
AR046330A1
(es)
|
2003-09-09 |
2005-12-07 |
Japan Tobacco Inc |
Inhibidor de dipeptidilpeptidasa iv
|
JP4722851B2
(ja)
|
2003-09-23 |
2011-07-13 |
メルク・シャープ・エンド・ドーム・コーポレイション |
キノリンカリウムチャネル阻害剤
|
WO2005030127A2
(fr)
|
2003-09-23 |
2005-04-07 |
Merck & Co., Inc. |
Nouvelle forme cristalline d'un sel d'acide phosphorique d'un inhibiteur de dipeptidyle peptase-iv
|
US20070043014A1
(en)
|
2003-10-01 |
2007-02-22 |
Merck & Co., Inc. |
3,5-Aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists
|
WO2005033099A2
(fr)
|
2003-10-03 |
2005-04-14 |
Glenmark Pharmaceuticals Ltd. |
Nouveaux inhibiteurs de dipeptidylpeptidase iv, leurs procedes de preparation et compositions les contenant
|
US20060089335A1
(en)
|
2003-10-14 |
2006-04-27 |
Guosong Liu |
Compositions and methods for enhancing cognitive function and synaptic plasticity
|
GB0324236D0
(en)
|
2003-10-16 |
2003-11-19 |
Astrazeneca Ab |
Chemical compounds
|
TW200523252A
(en)
|
2003-10-31 |
2005-07-16 |
Takeda Pharmaceutical |
Pyridine compounds
|
US7638637B2
(en)
|
2003-11-03 |
2009-12-29 |
University Of Virginia Patent Foundation |
Orally available sphingosine 1-phosphate receptor agonists and antagonists
|
WO2005044780A1
(fr)
|
2003-11-10 |
2005-05-19 |
Kyorin Pharmaceutical Co., Ltd. |
Derive d'acide aminocarboxylique, son sel d'addition et agent de regulation du recepteur s1p
|
TW200528106A
(en)
|
2003-11-10 |
2005-09-01 |
Synta Pharmaceuticals Corp |
Pyridine compounds
|
KR100918322B1
(ko)
|
2003-11-12 |
2009-09-22 |
페노믹스 코포레이션 |
헤테로시클릭 보론산 화합물
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
WO2005058315A1
(fr)
|
2003-12-12 |
2005-06-30 |
Ribapharm, Inc. |
Nouveaux composes heterocycliques utilises comme inhibiteurs et presentant une activite anti-hbv
|
WO2005058849A1
(fr)
|
2003-12-15 |
2005-06-30 |
Glenmark Pharmaceuticals Ltd. |
Nouveaux inhibiteurs de dipeptidyle peptidase iv, leur procede de preparation et compositions les contenant
|
WO2005058848A1
(fr)
|
2003-12-17 |
2005-06-30 |
Merck & Co., Inc. |
Carboxylates propanoiques 3,4-disusbstitues utilises en tant qu'agonistes du recepteur s1p (edg)
|
ATE528276T1
(de)
|
2003-12-19 |
2011-10-15 |
Ono Pharmaceutical Co |
Lysophosphatidylsäurerezeptor-antagonistische verbindungen und ihre anwendungen
|
GB0329498D0
(en)
|
2003-12-19 |
2004-01-28 |
Novartis Ag |
Organic compounds
|
DE10360835A1
(de)
|
2003-12-23 |
2005-07-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Bicyclische Imidazolverbindungen, deren Herstellung und deren Verwendung als Arzneimittel
|
JP4958560B2
(ja)
|
2003-12-24 |
2012-06-20 |
プロシディオン・リミテッド |
Gpcr受容体作動薬としてのヘテロ環誘導体
|
US20080227786A1
(en)
|
2004-01-16 |
2008-09-18 |
Ferlita Russell R |
Novel Crystalline Salts of a Dipeptidyl Peptidase-IV Inhibitor
|
GB0401332D0
(en)
|
2004-01-21 |
2004-02-25 |
Novartis Ag |
Organic compounds
|
WO2005075426A1
(fr)
|
2004-02-03 |
2005-08-18 |
Glenmark Pharmaceuticals Ltd. |
Nouveaux inhibiteurs de dipeptidyle peptidase iv, leur procedes de preparation et compositions en comportant
|
JP2007522233A
(ja)
|
2004-02-11 |
2007-08-09 |
アムジエン・インコーポレーテツド |
バニロイド受容体リガンド及び治療におけるそれらの使用
|
TW200530236A
(en)
|
2004-02-23 |
2005-09-16 |
Chugai Pharmaceutical Co Ltd |
Heteroaryl phenylurea
|
WO2005082841A1
(fr)
|
2004-02-24 |
2005-09-09 |
Irm Llc |
Composes et compositions d'immunosuppresseurs
|
WO2005079788A1
(fr)
|
2004-02-24 |
2005-09-01 |
Sankyo Company, Limited |
Composé d’alcool aminé
|
TW200538433A
(en)
|
2004-02-24 |
2005-12-01 |
Irm Llc |
Immunosuppressant compounds and compositiions
|
WO2005085214A1
(fr)
|
2004-03-05 |
2005-09-15 |
Banyu Pharmaceutical Co., Ltd |
Dérivé hétérocyclique à cinq éléments substitués par un diaryle
|
GB0405289D0
(en)
|
2004-03-09 |
2004-04-21 |
Novartis Ag |
Organic compounds
|
GB0405933D0
(en)
|
2004-03-16 |
2004-04-21 |
Glaxo Group Ltd |
Compounds
|
EP1737820B1
(fr)
|
2004-04-02 |
2008-01-16 |
Merck & Co., Inc. |
Procede d'hydrogenation asymetrique utile pour la preparation de derives de cycloalcanoindole
|
BRPI0509795A
(pt)
|
2004-04-12 |
2007-10-23 |
Sankyo Co |
composto ou um sal farmacologicamente aceitável do mesmo, composição farmacêutica, uso do composto ou sal farmacologicamente aceitável do mesmo, e, método para promover osteogênese, supressão de ressorção óssea e/ou melhoramento da densidade óssea
|
EP1750727A2
(fr)
|
2004-04-23 |
2007-02-14 |
Exelixis, Inc. |
Modulateurs des proteines kinases et leurs methodes d'utilisation
|
WO2005121121A2
(fr)
|
2004-06-04 |
2005-12-22 |
Arena Pharmaceuticals, Inc. |
Derives d'aryle et d'heteroaryle substitues tenant lieu de modulateurs du metabolisme et prevention et traitement de troubles associes
|
WO2005123677A1
(fr)
|
2004-06-16 |
2005-12-29 |
Actelion Pharmaceuticals Ltd |
Utilisation de derives de 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa[a]pentalene a substitution 4-carbonyle comme agonistes du recepteur couple aux proteines g s1p1/edg1 et agents immunosuppresseurs
|
JP5315611B2
(ja)
|
2004-06-23 |
2013-10-16 |
小野薬品工業株式会社 |
S1p受容体結合能を有する化合物およびその用途
|
PL1772145T3
(pl)
|
2004-07-16 |
2011-08-31 |
Kyorin Seiyaku Kk |
Sposób skutecznego stosowania leku i sposób dotyczący zapobiegania efektom ubocznym
|
JP2007284350A
(ja)
|
2004-07-27 |
2007-11-01 |
Takeda Chem Ind Ltd |
糖尿病治療剤
|
WO2006010379A1
(fr)
|
2004-07-29 |
2006-02-02 |
Actelion Pharmaceuticals Ltd. |
Nouveaux derives du thiophene utilises comme agents immunosupresseurs
|
TW200611687A
(en)
|
2004-07-29 |
2006-04-16 |
Sankyo Co |
Pharmaceutical compositions used for immunosuppressant
|
EP1798226A4
(fr)
|
2004-08-04 |
2009-06-17 |
Taisho Pharmaceutical Co Ltd |
Derive de traizol
|
US20060223866A1
(en)
|
2004-08-13 |
2006-10-05 |
Praecis Pharmaceuticals, Inc. |
Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
|
RU2007109207A
(ru)
|
2004-08-13 |
2008-09-20 |
Прикис Фамэсьютикэлс, Инк. (US) |
Соединения-модуляторы активности рецептора сфингозин-1-фосфата (варианты), фармацевтическая композиция, содержащая указанные соединения, и способ лечения нарушения, ассоциированного со сфингозин-1-фосфатом
|
AR051095A1
(es)
|
2004-09-20 |
2006-12-20 |
Xenon Pharmaceuticals Inc |
Derivados heterociclicos y su uso comoinhibidores de la estearoil-coa desaturasa
|
JP2008514611A
(ja)
|
2004-09-23 |
2008-05-08 |
ワイス |
C型肝炎ウイルスによる感染を処置するためのカルバゾールおよびシクロペンタインドールの誘導体
|
EP1796669B1
(fr)
|
2004-10-01 |
2010-09-22 |
Merck Sharp & Dohme Corp. |
Aminopiperidines utilisees comme inhibiteurs de la dipeptidyle peptidase-iv pour le traitement ou la prevention du diabete
|
CA2583259C
(fr)
|
2004-10-08 |
2011-08-02 |
Astellas Pharma Inc. |
Derive polycyclique aromatique de pyrimidine
|
US7189748B2
(en)
|
2004-10-12 |
2007-03-13 |
Forbes Medi-Tech (Research), Inc. |
Compounds and methods for treating insulin resistance and cardiomyopathy
|
TW200621257A
(en)
|
2004-10-20 |
2006-07-01 |
Astellas Pharma Inc |
Pyrimidine derivative fused with nonaromatic ring
|
DK1650186T3
(da)
|
2004-10-22 |
2008-10-13 |
Sun Pharmaceutical Ind Ltd |
Nye dicarboxylsyrederivater
|
WO2006047195A2
(fr)
|
2004-10-22 |
2006-05-04 |
Merck & Co., Inc. |
Carboxylates, sulfonates, phosphonates, phosphinates 2-(aryl)azacyclylmethyle et heterocycles utilises comme agonistes des recepteurs s1p
|
AR051596A1
(es)
|
2004-10-26 |
2007-01-24 |
Irm Llc |
Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios
|
JP5785354B2
(ja)
|
2004-11-03 |
2015-09-30 |
アリーナ ファーマシューティカルズ, インコーポレイテッド |
インスリン関連障害の処置のためのgpr41およびその調節因子
|
GB0425035D0
(en)
|
2004-11-12 |
2004-12-15 |
Novartis Ag |
Organic compounds
|
AU2005307718A1
(en)
|
2004-11-18 |
2006-05-26 |
The Institutes For Pharmaceutical Discovery, Llc |
Heterocycle substituted carboxylic acids for the treatment of diabetes
|
EP1829863A4
(fr)
|
2004-11-26 |
2009-04-22 |
Takeda Pharmaceutical |
Derive d'acide arylalcanoique
|
JP2008522977A
(ja)
|
2004-12-06 |
2008-07-03 |
ユニバーシティ オブ バージニア パテント ファンデーション |
スフィンゴシン=1−リン酸のアリールアミドアナログ
|
BRPI0519006A2
(pt)
|
2004-12-13 |
2008-12-23 |
Daiichi Sankyo Co Ltd |
uso de um inibidor de fbpase, kit de uma composiÇço farmacÊutica, uso de uma preparaÇço de biguanida e um inibidor de fbpase, agente terapÊutico para diabetes melito, e, combinaÇço de agentes terapÊuticos
|
ATE541830T1
(de)
|
2004-12-13 |
2012-02-15 |
Ono Pharmaceutical Co |
Aminocarbonsäurederivat und dessen medizinische verwendung
|
JP4980928B2
(ja)
|
2004-12-24 |
2012-07-18 |
プロシディオン・リミテッド |
Gタンパク質共役受容体(gpr116)作動薬および肥満および糖尿病治療のためのその使用
|
WO2006067532A1
(fr)
|
2004-12-24 |
2006-06-29 |
Prosidion Ltd |
Agonistes du récepteur couplé aux protéines g
|
GB0428514D0
(en)
|
2004-12-31 |
2005-02-09 |
Prosidion Ltd |
Compounds
|
DOP2006000008A
(es)
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
|
MY148521A
(en)
|
2005-01-10 |
2013-04-30 |
Arena Pharm Inc |
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
|
DOP2006000010A
(es)
|
2005-01-10 |
2006-07-31 |
Arena Pharm Inc |
Procedimiento para preparar eteres aromáticos
|
DOP2006000009A
(es)
|
2005-01-13 |
2006-08-15 |
Arena Pharm Inc |
Procedimiento para preparar eteres de pirazolo [3,4-d] pirimidina
|
AU2006206246A1
(en)
|
2005-01-19 |
2006-07-27 |
Neurogen Corporation |
Heteroaryl substituted piperazinyl-pyridine analogues
|
JP5798282B2
(ja)
|
2005-01-25 |
2015-10-21 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
メソゲン性化合物、液晶媒体および液晶ディスプレイ
|
EP1685841A1
(fr)
|
2005-01-31 |
2006-08-02 |
Bayer Health Care Aktiengesellschaft |
Prevention et traitement de troubles thromboemboliques
|
US7754703B2
(en)
|
2005-02-14 |
2010-07-13 |
University Of Virginia Patent Foundation |
Cycloalkane-containing sphingosine 1-phosphate agonists
|
JP5063581B2
(ja)
|
2005-03-23 |
2012-10-31 |
アクテリオン ファーマシューティカルズ リミテッド |
新規チオフェン誘導体
|
RU2412179C2
(ru)
|
2005-03-23 |
2011-02-20 |
Актелион Фармасьютиклз Лтд |
Гидрированные производные бензо[с]тиофена в качестве иммуномодуляторов
|
MX2007011672A
(es)
|
2005-03-23 |
2007-11-15 |
Actelion Pharmaceuticals Ltd |
Nuevos derivados de tiofeno como agonistas del receptor de esfingosina-1-fosfato-1.
|
JP2008545767A
(ja)
|
2005-06-08 |
2008-12-18 |
ノバルティス アクチエンゲゼルシャフト |
多環式オキサジアゾールまたはイソキサゾールおよびsip受容体リガンドとしてのそれらの使用
|
MX2007016505A
(es)
|
2005-06-24 |
2008-03-07 |
Actelion Pharmaceuticals Ltd |
Nuevos derivados de tiofeno.
|
TWI418350B
(zh)
|
2005-06-24 |
2013-12-11 |
Sankyo Co |
含有ppar調節劑之醫藥組成物的用途
|
NZ564758A
(en)
|
2005-06-30 |
2011-03-31 |
Prosidion Ltd |
G-protein coupled receptor agonists
|
ATE527253T1
(de)
|
2005-07-01 |
2011-10-15 |
Irm Llc |
Pyrimidin-substituierte benzimidazolderivate als proteinkinasehemmer
|
US20070060573A1
(en)
|
2005-08-10 |
2007-03-15 |
Lars Wortmann |
Acyltryptophanols
|
AU2006283175A1
(en)
|
2005-08-23 |
2007-03-01 |
Irm Llc |
Immunosuppressant compounds and compositions
|
NZ565898A
(en)
|
2005-09-16 |
2010-07-30 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
TW200745055A
(en)
|
2005-09-23 |
2007-12-16 |
Organon Nv |
4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
|
WO2007037196A1
(fr)
|
2005-09-29 |
2007-04-05 |
Yamamoto Chemicals, Inc. |
Composé indoline et procédé pour le produire
|
PT1932522E
(pt)
*
|
2005-10-07 |
2012-06-26 |
Kyorin Seiyaku Kk |
Agente terapêutico para doenças do fígado contendo, como princípio activo, um derivado de 2- amino-1,3-propanodiol
|
AR057894A1
(es)
|
2005-11-23 |
2007-12-26 |
Actelion Pharmaceuticals Ltd |
Derivados de tiofeno
|
JP2009520688A
(ja)
|
2005-11-23 |
2009-05-28 |
エピックス デラウェア, インコーポレイテッド |
S1p受容体調節化合物およびそれらの使用
|
ES2684821T3
(es)
|
2005-12-29 |
2018-10-04 |
Lexicon Pharmaceuticals, Inc. |
Derivados de aminoácidos multicíclicos y métodos de su uso
|
TWI404706B
(zh)
|
2006-01-11 |
2013-08-11 |
Actelion Pharmaceuticals Ltd |
新穎噻吩衍生物
|
TW200736234A
(en)
|
2006-01-17 |
2007-10-01 |
Astrazeneca Ab |
Chemical compounds
|
WO2007083182A2
(fr)
|
2006-01-19 |
2007-07-26 |
Orchid Research Laboratories Limited |
Nouveaux hétérocycles
|
JP5063615B2
(ja)
|
2006-01-24 |
2012-10-31 |
アクテリオン ファーマシューティカルズ リミテッド |
新規ピリジン誘導体
|
GB0601744D0
(en)
|
2006-01-27 |
2006-03-08 |
Novartis Ag |
Organic compounds
|
TWI389683B
(zh)
|
2006-02-06 |
2013-03-21 |
Kyorin Seiyaku Kk |
A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
|
TW200806611A
(en)
|
2006-02-09 |
2008-02-01 |
Daiichi Seiyaku Co |
Novel amidopropionic acid derivatives and medicine containing the same
|
CA2641718A1
(fr)
|
2006-02-09 |
2007-08-16 |
University Of Virginia Patent Foundation |
Analogues de sphingosine 1-phosphate bicyclique
|
US20070191371A1
(en)
|
2006-02-14 |
2007-08-16 |
Kalypsys, Inc. |
Heterocyclic modulators of ppar
|
CA2642668C
(fr)
|
2006-02-15 |
2013-01-08 |
Allergan, Inc. |
Composes d'amides et esters d'acide indole-3-carboxylique comportant des groupes phenyles ayant une activite biologique antagoniste du recepteur sphingosine-1-phosphate (s1p)
|
CN101460458A
(zh)
|
2006-02-15 |
2009-06-17 |
阿勒根公司 |
具有1-磷酸-鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚-3-羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
|
WO2007098474A1
(fr)
|
2006-02-21 |
2007-08-30 |
University Of Virginia Patent Foundation |
Composés de phényl-cycloalkyl contenant des structures à anneau hétérocyclique
|
US7649098B2
(en)
|
2006-02-24 |
2010-01-19 |
Lexicon Pharmaceuticals, Inc. |
Imidazole-based compounds, compositions comprising them and methods of their use
|
EP2001844A2
(fr)
|
2006-03-14 |
2008-12-17 |
Amgen, Inc |
Derives bicycliques de l'acide carboxylique utiles dans le traitement de troubles metaboliques
|
CA2646469A1
(fr)
|
2006-03-21 |
2007-09-27 |
Epix Delaware, Inc. |
Composes modulant le recepteur de la sip
|
JP2007262009A
(ja)
|
2006-03-29 |
2007-10-11 |
Dai Ichi Seiyaku Co Ltd |
ヘテロアリール低級カルボン酸誘導体
|
BRPI0709866B8
(pt)
|
2006-04-03 |
2021-05-25 |
Astellas Pharma Inc |
compostos héteros e composição farmacêutica compreendendo ditos compostos
|
UA97479C2
(ru)
|
2006-04-11 |
2012-02-27 |
Арена Фармасьютикалз, Инк. |
Применение g-белок-связанного рецептора (gpcr) для идентификации средств, которые усиливают секрецию глюкозозависимого инсулинотропного пептида (gi)
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
GB0607389D0
(en)
|
2006-04-12 |
2006-05-24 |
Novartis Ag |
Organic compounds
|
WO2007129473A1
(fr)
|
2006-05-09 |
2007-11-15 |
Daiichi Sankyo Company, Limited |
Dérivé arylique bicyclique
|
EA200802058A1
(ru)
|
2006-05-09 |
2009-06-30 |
Пфайзер Продактс Инк. |
Производные циклоалкиламинокислот и их фармацевтические композиции
|
US20090324581A1
(en)
|
2006-05-09 |
2009-12-31 |
Daiichi Sankyo Company Limited |
Heteroarylamide lower carboxylic acid derivative
|
TW200811147A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
TW200811140A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
EP2043744A2
(fr)
|
2006-07-13 |
2009-04-08 |
SmithKline Beecham Corporation |
Composés chimiques
|
AR062156A1
(es)
|
2006-08-01 |
2008-10-22 |
Praecis Pharm Inc |
Compuestos agonistas y selectivos del receptor s1p-1
|
JP2009545597A
(ja)
|
2006-08-01 |
2009-12-24 |
プリーシス・ファーマシューティカルズ・インコーポレイテッド |
スフィンゴシン−1−ホスフェート受容体(slp)のアゴニスト
|
EP2099768A2
(fr)
|
2006-08-04 |
2009-09-16 |
Praecis Pharmaceuticals Incorporated |
Agonistes du recepteur de sphingosine-1-phosphate
|
CN101501049B
(zh)
|
2006-08-08 |
2013-04-24 |
杏林制药株式会社 |
氨基磷酸酯衍生物以及将它们作为有效成分的s1p受体调节剂
|
JP2010501555A
(ja)
|
2006-08-24 |
2010-01-21 |
プリーシス・ファーマシューティカルズ・インコーポレイテッド |
S1p−1受容体アゴニスト
|
JP2009269819A
(ja)
|
2006-08-25 |
2009-11-19 |
Asahi Kasei Pharma Kk |
アミン化合物
|
WO2008025799A1
(fr)
|
2006-08-30 |
2008-03-06 |
Biovitrum Ab (Publ) |
Composés de pyridazine permettant de traiter les troubles liés à gpr119
|
AU2007292347A1
(en)
|
2006-09-07 |
2008-03-13 |
Allergan, Inc. |
Heteroaromatic compounds having sphingosine-1-phosphate (S1P) receptor agonist and/or antagonist biological activity
|
SI2069336T1
(sl)
|
2006-09-07 |
2013-03-29 |
Actelion Pharmaceuticals Ltd. |
Derivati piridin-4-ila kot imunomodulirna sredstva
|
TWI408139B
(zh)
|
2006-09-07 |
2013-09-11 |
Actelion Pharmaceuticals Ltd |
新穎噻吩衍生物
|
KR20090060333A
(ko)
|
2006-09-08 |
2009-06-11 |
노파르티스 아게 |
림프구 상호작용에 의해 매개되는 질환의 치료에 유용한 n-바이아릴 (헤테로)아릴술폰아미드 유도체
|
RU2442780C2
(ru)
|
2006-09-21 |
2012-02-20 |
Актелион Фармасьютиклз Лтд |
Фенильные производные и их применение в качестве иммуномодуляторов
|
CN101657471B
(zh)
|
2006-12-06 |
2013-07-03 |
史密丝克莱恩比彻姆公司 |
二环化合物及其作为抗糖尿病药的用途
|
JP2010513272A
(ja)
|
2006-12-14 |
2010-04-30 |
メルク エンド カムパニー インコーポレーテッド |
アシルビピペリジニル化合物、そのような化合物を含む組成物、及び治療方法
|
NZ577111A
(en)
|
2006-12-15 |
2012-05-25 |
Abbott Lab |
Novel oxadiazole compounds
|
JO2701B1
(en)
|
2006-12-21 |
2013-03-03 |
جلاكسو جروب ليميتد |
Vehicles
|
EP2120575A4
(fr)
|
2006-12-21 |
2011-04-27 |
Abbott Lab |
Composés d'agonistes et d'antagonistes des récepteurs de sphingosine-1-phosphate
|
GB0625648D0
(en)
|
2006-12-21 |
2007-01-31 |
Glaxo Group Ltd |
Compounds
|
CA2674946A1
(fr)
|
2007-01-11 |
2008-07-24 |
Allergan, Inc. |
Compose amide d'acide indole-3-carboxylique 6-substitue ayant une activite biologique d'antagoniste du recepteur de sphingosine-1-phosphate (s1p)
|
WO2008091967A1
(fr)
|
2007-01-26 |
2008-07-31 |
Smithkline Beecham Corporation |
Composés chimiques
|
WO2008097819A2
(fr)
|
2007-02-05 |
2008-08-14 |
Smithkline Beecham Corporation |
Composés chimiques
|
CN101627034B
(zh)
|
2007-03-16 |
2013-05-15 |
埃科特莱茵药品有限公司 |
氨基-吡啶衍生物作为s1p1/edg1受体激动剂
|
AU2007227278B2
(en)
|
2007-03-21 |
2014-09-11 |
Epix Pharmaceuticals, Inc. |
SIP receptor modulating compounds and use thereof
|
WO2008128832A1
(fr)
|
2007-04-18 |
2008-10-30 |
Nicox S.A. |
Nitrodérivés non peptidiques d'inhibiteurs de la rénine destinés au traitement de maladies cardiovasculaires, rénales et chroniques du foie, des inflammations et du syndrome métabolique
|
CL2008001099A1
(es)
|
2007-04-19 |
2008-10-24 |
Glaxo Group Ltd |
Compuestos derivados de indazol; y su uso para tratar enfermedades mediadas por los receptores s1p1, tales como esclerosis multiple, enfermedad autoinmune, trastornos inflamatorios, diabetes, entre otras.
|
ES2388967T3
(es)
|
2007-05-04 |
2012-10-22 |
Bristol-Myers Squibb Company |
Agonistas [6,6]- y [6,7]-bicíclicos del receptor GPR119 acoplado a la proteína G
|
EP2014653A1
(fr)
|
2007-06-15 |
2009-01-14 |
Bioprojet |
Nouveaux dérivés d'acide dicarboxylique comme agonistes du recepteur S1P1
|
WO2009011850A2
(fr)
|
2007-07-16 |
2009-01-22 |
Abbott Laboratories |
Nouveaux composés thérapeutiques
|
WO2009019506A1
(fr)
|
2007-08-03 |
2009-02-12 |
Astrazeneca Ab |
Sulfonamides hétérocycliques ayant une activité antagoniste de edg-1
|
BRPI0814975A2
(pt)
|
2007-08-08 |
2015-02-03 |
Merck Serono Sa |
Derivados de 6-amino-pirimidina-4-carboxamida e compostos relacionados que se ligam ao receptor de 1-fosfato de esfingosina (s1p) para o tratamento de esclerose múltipla
|
CN101801954B
(zh)
|
2007-09-20 |
2013-10-09 |
Irm责任有限公司 |
作为gpr119活性调节剂的化合物和组合物
|
UY31468A1
(es)
|
2007-11-15 |
2009-07-17 |
|
Derivados bis-(sulfonilamino) en terapia 065
|
EP2225201A2
(fr)
|
2007-11-28 |
2010-09-08 |
Synta Pharmaceuticals Corp. |
Polymorphes de n-malonyl-bis(n'-méthyl-n'-thiobenzoylhydrazide)
|
AU2008338965A1
(en)
|
2007-12-18 |
2009-06-25 |
Arena Pharmaceuticals, Inc. |
Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
|
WO2009094157A1
(fr)
|
2008-01-25 |
2009-07-30 |
Arena Pharmaceuticals, Inc. |
Dérivés carboxyliques dihydro-1h-pyrrolo[1,2-a]indol-1-yle agissant comme des agonistes de s1p1
|
AR070398A1
(es)
|
2008-02-22 |
2010-03-31 |
Gruenenthal Chemie |
Derivados sustituidos de indol
|
EP2258040A2
(fr)
|
2008-02-28 |
2010-12-08 |
Solar Roofing Systems, Inc. |
Tuile photovoltaïque avec matériau anti-incendie
|
CN101980704A
(zh)
|
2008-03-17 |
2011-02-23 |
埃科特莱茵药品有限公司 |
选择性s1p1受体激动剂的给药方案
|
WO2009126535A1
(fr)
|
2008-04-07 |
2009-10-15 |
Irm Llc |
Composés et compositions servant de modulateurs de l’activité de gpr119
|
EP2108960A1
(fr)
|
2008-04-07 |
2009-10-14 |
Arena Pharmaceuticals, Inc. |
Procédés d'utilisation d'un récepteur couplé à protéine G pour identifier les secrétagogues de peptide YY (PYY) et composés utiles dans le traitement des conditions modulées de secrétagogues BY (PYY) et composés utiles dans le traitement des conditions par PYY
|
WO2009125434A2
(fr)
|
2008-04-07 |
2009-10-15 |
Cadila Healthcare Limited |
Dérivés d’oxime
|
PT2291080E
(pt)
|
2008-05-14 |
2015-10-30 |
Scripps Research Inst |
Novos modelamodeladores dos recetores da esfingosina fosfato
|
WO2009151626A1
(fr)
|
2008-06-13 |
2009-12-17 |
Arena Pharmaceuticals, Inc. |
Dérivés de l’acide (1, 2, 4-oxadiazol-3-yl)indolin-1-yl carboxylique substitué pouvant être utilisés comme agonistes de s1p1
|
WO2009151621A1
(fr)
|
2008-06-13 |
2009-12-17 |
Arena Pharmaceuticals, Inc. |
Dérivés de l’acide (1, 2, 4-oxadiazol-3-yl)indolin-1-yl carboxylique substitué utiles comme agonistes de s1p1
|
EP2326621B1
(fr)
|
2008-07-23 |
2016-06-08 |
Arena Pharmaceuticals, Inc. |
Dérivés de l acide 1,2,3,4-tétrahydrocyclopenta[b]indol-3-yle acétique substitué utilisés dans le traitement des maladies auto-immunes et inflammatoires
|
RS54970B1
(sr)
|
2008-08-27 |
2016-11-30 |
Arena Pharm Inc |
Supstituisani triciklični derivati kiselina kao s1p1 receptor agonisti korisni pri lečenju autoimunih i upalnih poremećaja
|
PL3409274T3
(pl)
|
2008-12-22 |
2020-06-01 |
Novartis Ag |
Schemat dawkowania dla agonisty receptora s1p
|
JO3044B1
(ar)
|
2008-12-22 |
2016-09-05 |
Novartis Ag |
نظام تناول جرعة لمنبه مستقبل s1p
|
WO2010075273A1
(fr)
|
2008-12-23 |
2010-07-01 |
Schering Corporation |
Dérivés d'hétérocycles bicycliques et leurs procédés d'utilisation
|
WO2010075271A1
(fr)
|
2008-12-23 |
2010-07-01 |
Schering Corporation |
Dérivés d'hétérocycles bicycliques et leurs procédés d'utilisation
|
WO2010074271A1
(fr)
|
2008-12-26 |
2010-07-01 |
武田薬品工業株式会社 |
Agent thérapeutique pour le diabète
|
WO2010084944A1
(fr)
|
2009-01-22 |
2010-07-29 |
田辺三菱製薬株式会社 |
NOUVEAU COMPOSÉ PYRROLO[2,3-d] PYRIMIDINE
|
RU2011137454A
(ru)
|
2009-02-10 |
2013-03-20 |
Эбботт Лэборетриз |
Агонисты и антагонисты s1p5-рецепторов и способы их применения
|
WO2011005290A1
(fr)
|
2009-06-23 |
2011-01-13 |
Arena Pharmaceuticals, Inc. |
Dérivés d'oxadiazole disubstitués utiles dans le traitement de troubles auto-immuns et inflammatoires
|
WO2011005295A1
(fr)
|
2009-06-24 |
2011-01-13 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur sphingosine-1-phosphate (s1p) utiles pour le traitement de troubles associés à ceux-ci
|
AR077642A1
(es)
|
2009-07-09 |
2011-09-14 |
Arena Pharm Inc |
Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
|
AR077638A1
(es)
|
2009-07-15 |
2011-09-14 |
Lilly Co Eli |
Compuesto de (metanosulfonil -piperidin )-( alcoxi-aril) -tetrahidro- piridina , composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento de diabetes u obesidad
|
WO2011030139A1
(fr)
|
2009-09-11 |
2011-03-17 |
Astrazeneca Ab |
Derives de 4-(pyrimidin-2-yl)-piperazine et de 4-(pyrimidin-2-yl)-piperidine utilises en tant que modulateurs du gpr119
|
EP2592071B1
(fr)
|
2009-10-29 |
2019-09-18 |
Bristol-Myers Squibb Company |
Composés hétérocycliques tricycliques
|
US8299059B2
(en)
|
2009-10-30 |
2012-10-30 |
Eli Lilly And Company |
Crystalline compound and a process for its preparation
|
US8440693B2
(en)
|
2009-12-22 |
2013-05-14 |
Novartis Ag |
Substituted isoquinolinones and quinazolinones
|
WO2011079969A1
(fr)
|
2009-12-30 |
2011-07-07 |
Medichem S.A. |
Dérivé de 1-(1h-1,2,4-triazol-1-yl)butan-2-ol à usage pharmaceutique et utilisation d'un dérivé de 1-(1h-1,2,4-triazol-1-yl)butan-2-ol présentant une forme cristalline en grande partie non définie pour la préparation dudit dérivé de 1-(1h-1,2,4-triazol-1-yl)butan-2-ol
|
EP3378854B1
(fr)
|
2010-01-27 |
2022-12-21 |
Arena Pharmaceuticals, Inc. |
Procédés de préparation d'acide (r)-2-(7-(4-cyclopentyl-3-(trifluorométhyl)benzyloxy)-1,2,3,4-tétrahydrocyclopenta[b]indol-3-yl) acétique et de ses sels
|
CA2789480A1
(fr)
|
2010-03-03 |
2011-09-09 |
Arena Pharmaceuticals, Inc. |
Procedes de synthese de modulateurs des recepteurs s1p1 et leurs formes cristallines
|
MX2012011631A
(es)
|
2010-04-06 |
2013-01-18 |
Arena Pharm Inc |
Moduladores del receptor gpr119 y el tratamiento de trastornos relacionados con el mismo.
|
JP2013533286A
(ja)
|
2010-07-30 |
2013-08-22 |
セントルイス ユニバーシティ |
疼痛を治療する方法
|
BR112013008100A2
(pt)
|
2010-09-22 |
2016-08-09 |
Arena Pharm Inc |
"moduladores do receptor de gpr19 e o tratamento de distúrbios relacionados a eles."
|
UA113507C2
(xx)
|
2011-02-07 |
2017-02-10 |
|
Модулятори s1p
|
US20140018371A1
(en)
|
2011-04-01 |
2014-01-16 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
WO2012145361A1
(fr)
|
2011-04-19 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur gpr119 et traitement de troubles liés à celui-ci
|
WO2012145604A1
(fr)
|
2011-04-22 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur gpr119 et traitement de troubles liés à celui-ci
|
WO2012145603A1
(fr)
|
2011-04-22 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur gpr119 et traitement de troubles liés à celui-ci
|
WO2012170702A1
(fr)
|
2011-06-08 |
2012-12-13 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur gpr119 et traitement de troubles associés à celui-ci
|
WO2013055910A1
(fr)
|
2011-10-12 |
2013-04-18 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur gpr119 et traitement de troubles associés
|
SG11201404214QA
(en)
|
2012-02-03 |
2014-08-28 |
Teva Pharma |
USE OF LAQUINIMOD FOR TREATING CROHN'S DISEASE PATIENTS WHO FAILED FIRST-LINE ANTI-TNFα THERAPY
|
US20160038506A1
(en)
|
2012-02-14 |
2016-02-11 |
Repros Therapeutics Inc. |
Selective Estrogen Receptor Modulators With Short Half-Lives and Uses Thereof
|
US8962888B2
(en)
|
2012-12-03 |
2015-02-24 |
Physical Sciences, Inc. |
Forming spherical crystal habit
|
JP5589110B1
(ja)
|
2013-03-08 |
2014-09-10 |
株式会社ポーラファルマ |
晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
|
AU2016205361C1
(en)
|
2015-01-06 |
2021-04-08 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the S1P1 receptor
|
SI3310760T1
(sl)
|
2015-06-22 |
2023-02-28 |
Arena Pharmaceuticals, Inc. |
Kristalinična L-argininska sol (R)-2-(7-(4-ciklopentil-3-(trifluorometil)benziloksi)-1,2,3,4- tetrahidrociklo-penta(b)indol-3-il)ocetne kisline za uporabo pri motnjah, povezanih z receptorjem S1P1
|
MA47503A
(fr)
|
2017-02-16 |
2021-04-21 |
Arena Pharm Inc |
Composés et méthodes pour le traitement de maladies inflammatoires chroniques de l'intestin avec manifestations extra-intestinales
|
KR20190116416A
(ko)
|
2017-02-16 |
2019-10-14 |
아레나 파마슈티칼스, 인크. |
원발 담즙성 담관염을 치료하기 위한 화합물 및 방법
|
CN112601516A
(zh)
|
2018-06-06 |
2021-04-02 |
艾尼纳制药公司 |
治疗与s1p1受体相关的病况的方法
|
JP7265620B2
(ja)
|
2018-10-03 |
2023-04-26 |
アリーナ ファーマシューティカルズ, インコーポレイテッド |
強皮症の治療のための方法
|
US20220023258A1
(en)
|
2018-11-30 |
2022-01-27 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the s1p1 receptor
|
AU2020206700A1
(en)
|
2019-01-08 |
2021-07-15 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the S1P
|